Sean P. Nolan is a businessperson who has been at the head of 6 different companies. Mr. Nolan occupies the position of Executive Chairman for Istari Oncology, Inc., Chairman of Encoded Therapeutics, Inc., Chairman of Taysha Gene Therapies, Inc. and Chairman & President at Nolan Capital LLC.
He is also on the board of Ventas, Inc., Affinia Therapeutics, Inc. and Social Capital Suvretta Holdings Corp. II.
He previously was Chief Commercial Officer for Reata Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Novartis Gene Therapies, Inc., President & Chief Commercial Officer at Lundbeck, Inc., Chief Business Officer & Executive Vice President at InterMune, Inc. and Vice President-Marketing & Sales Operations at OVATION Pharmaceuticals, Inc.
Mr. Nolan received an undergraduate degree from John Carroll University.